Cargando…

Potent SARS-CoV-2 Direct-Acting Antivirals Provide an Important Complement to COVID-19 Vaccines

Detalles Bibliográficos
Autores principales:	Pelly, Stephen, Liotta, Dennis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7945585/ https://www.ncbi.nlm.nih.gov/pubmed/33786374 http://dx.doi.org/10.1021/acscentsci.1c00258

Ejemplares similares

The Metallodrug BOLD-100 Is a Potent Inhibitor of SARS-CoV-2 Replication and Has Broad-Acting Antiviral Activity
por: Labach, Daniel S., et al.
Publicado: (2023)

Potent antiviral effect of silver nanoparticles on SARS-CoV-2
por: Jeremiah, Sundararaj S., et al.
Publicado: (2020)

Mannose-Binding Lectins as Potent Antivirals against SARS-CoV-2
por: Grosche, Victória Riquena, et al.
Publicado: (2023)

Potent Antiviral Activities of Type I Interferons to SARS-CoV-2 Infection
por: Mantlo, Emily, et al.
Publicado: (2020)

Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2
por: Xiao, Xia, et al.
Publicado: (2020)

Time to ‘Mind the Gap’ in novel small molecule drug discovery for direct-acting antivirals for SARS-CoV-2
por: Jonsson, Colleen B, et al.
Publicado: (2021)

A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine
por: Jangra, Sonia, et al.
Publicado: (2021)

Potent Antiviral Activity against HSV-1 and SARS-CoV-2 by Antimicrobial Peptoids
por: Diamond, Gill, et al.
Publicado: (2021)

EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2
por: Roshdy, Wael H., et al.
Publicado: (2020)

Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals
por: Sun, Le-Yun, et al.
Publicado: (2021)

Hypochlorous acid solution is a potent antiviral agent against SARS‐CoV‐2
por: Hatanaka, Noritoshi, et al.
Publicado: (2021)

Multi-target direct-acting SARS-CoV-2 antivirals against the nucleotide-binding pockets of virus-specific proteins
por: Rani, Ruchi, et al.
Publicado: (2022)

Bovine Interferon Lambda Is a Potent Antiviral Against SARS-CoV-2 Infection in vitro
por: Cardoso, Nancy Patricia, et al.
Publicado: (2020)

Potent antiviral activity of Agrimonia pilosa, Galla rhois, and their components against SARS-CoV-2
por: Lee, Yeong-Geun, et al.
Publicado: (2021)

SARS-CoV-2 Fears Green: The Chlorophyll Catabolite Pheophorbide A Is a Potent Antiviral
por: Jimenez-Aleman, Guillermo H., et al.
Publicado: (2021)

Cyclosporin A Reveals Potent Antiviral Effects in Preclinical Models of SARS-CoV-2 Infection
por: Sauerhering, Lucie, et al.
Publicado: (2022)

Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2
por: Gaynor, Katherine U., et al.
Publicado: (2023)

Re-purposing of hepatitis C virus FDA approved direct acting antivirals as potential SARS-CoV-2 protease inhibitors
por: Uddin, Reaz, et al.
Publicado: (2022)

Potent Antiviral Activities of the Direct-Acting Antivirals ABT-493 and ABT-530 with Three-Day Monotherapy for Hepatitis C Virus Genotype 1 Infection
por: Lawitz, Eric J., et al.
Publicado: (2016)

HIV/HCV Antiviral Drug Interactions in the Era of Direct-acting Antivirals
por: Rice, Donald P., et al.
Publicado: (2016)

Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines
por: Abdel-Moneim, Ahmed S., et al.
Publicado: (2021)

Low Complement C4 Predicts Improvement of Kidney Function After Direct‐Acting Antiviral Therapy for Hepatitis C Virus
por: Sise, Meghan E., et al.
Publicado: (2020)

5-Hydroxymethyltubercidin exhibits potent antiviral activity against flaviviruses and coronaviruses, including SARS-CoV-2
por: Uemura, Kentaro, et al.
Publicado: (2021)

GNS561 Exhibits Potent Antiviral Activity against SARS-CoV-2 through Autophagy Inhibition
por: Bestion, Eloïne, et al.
Publicado: (2022)

Structure-guided design of direct-acting antivirals that exploit the gem-dimethyl effect and potently inhibit 3CL proteases of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) and middle east respiratory syndrome coronavirus (MERS-CoV)
por: Dampalla, Chamandi S., et al.
Publicado: (2023)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
por: Elshabrawy, Hatem A.
Publicado: (2020)

The MEK1/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 Drugs
por: Schreiber, André, et al.
Publicado: (2022)

SARS-CoV-2 vaccine — think globally, act locally
por: Gea-Mallorquí, Ester, et al.
Publicado: (2020)

SARS-CoV-2 vaccine boosters: The time to act is now
por: Petersen, Maya, et al.
Publicado: (2021)

Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication
por: Garcia, Gustavo, et al.
Publicado: (2021)

Chlorine dioxide is a more potent antiviral agent against SARS-CoV-2 than sodium hypochlorite
por: Hatanaka, N., et al.
Publicado: (2021)

SARS-CoV-2 ORF7a potently inhibits the antiviral effect of the host factor SERINC5
por: Timilsina, Uddhav, et al.
Publicado: (2022)

Exploration of Potent Antiviral Phytomedicines from Lauraceae Family Plants against SARS-CoV-2 Main Protease
por: Bora, Himashree, et al.
Publicado: (2022)

GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial
por: Capone, Stefania, et al.
Publicado: (2023)

The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ?
por: Jans, David A., et al.
Publicado: (2021)

Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis
por: Karayiannis, Peter
Publicado: (2012)

Direct-acting antiviral retreatment patterns for hepatitis C
por: Hasan, Shaquib Al, et al.
Publicado: (2022)

High sustained virological response rates using imported generic direct acting antiviral treatment for hepatitis C
por: Hill, Andrew, et al.
Publicado: (2017)

Cationic nanocarriers as potent adjuvants for recombinant S-RBD vaccine of SARS-CoV-2
por: Lei, Hong, et al.
Publicado: (2020)

Prevention strategies for blood‐borne viruses—in the Era of vaccines, direct acting antivirals and antiretroviral therapy
por: Pfaender, Stephanie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_g48sd1gkh7i5sbo4rbe2qsdek9